Latest Insider Transactions at Outlook Therapeutics, Inc. (OTLK)
This section provides a real-time view of insider transactions for Outlook Therapeutics, Inc. (OTLK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outlook Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outlook Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2024
|
Syntone Ventures LLC |
BUY
Open market or private purchase
|
Direct |
714,286
+29.52%
|
-
|
|
Mar 28
2024
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
1,881
+27.15%
|
$20,691
$11.82 P/Share
|
|
Mar 18
2024
|
Ghiath M. Sukhtian Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,305,714
+28.42%
|
-
|
|
Mar 07
2024
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
62,484
+7.17%
|
$0
$0.42 P/Share
|
|
Apr 20
2023
|
Terry Dagnon Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
520,000
-44.33%
|
$520,000
$1.14 P/Share
|
|
Jan 20
2023
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
267,000
-26.36%
|
$267,000
$1.11 P/Share
|
|
Jan 19
2023
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
103,255
-9.25%
|
$103,255
$1.22 P/Share
|
|
Jan 18
2023
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
33,738
-2.93%
|
$33,738
$1.25 P/Share
|
|
Jan 17
2023
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
27,162
-2.31%
|
$27,162
$1.31 P/Share
|
|
Dec 28
2022
|
Ghiath M. Sukhtian Director |
BUY
Grant, award, or other acquisition
|
Indirect |
14,230,418
+16.89%
|
$0
$0.88 P/Share
|
|
Oct 07
2022
|
Faisal Ghiath Sukhtian |
BUY
Open market or private purchase
|
Direct |
30,000
+30.61%
|
$30,000
$1.29 P/Share
|
|
Oct 07
2022
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
3,600
+5.38%
|
$3,600
$1.27 P/Share
|
|
Oct 06
2022
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
29,743
+33.24%
|
$29,743
$1.29 P/Share
|
|
Oct 05
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
15,662
+3.2%
|
$15,662
$1.23 P/Share
|
|
Oct 04
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
95,541
+17.28%
|
$95,541
$1.29 P/Share
|
|
Oct 03
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
41,798
+10.35%
|
$41,798
$1.25 P/Share
|
|
Sep 30
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
33,199
+9.4%
|
$33,199
$1.26 P/Share
|
|
Sep 29
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
13,800
+4.59%
|
$13,800
$1.19 P/Share
|
|
Jun 21
2022
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
19,925
+26.62%
|
$19,925
$1.06 P/Share
|
|
Jun 21
2022
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.85%
|
$10,000
$1.05 P/Share
|
|
Apr 21
2022
|
Bio Lexis Pte Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
27,982,529
-54.91%
|
-
|
|
Apr 21
2022
|
Faisal Ghiath Sukhtian |
BUY
Other acquisition or disposition
|
Indirect |
27,982,529
+33.39%
|
-
|
|
Mar 01
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
27,708
+9.21%
|
$27,708
$1.69 P/Share
|
|
Feb 28
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
6,000
+2.39%
|
$6,000
$1.6 P/Share
|
|
Feb 24
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
41,160
+14.67%
|
$41,160
$1.46 P/Share
|
|
Feb 23
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
79,535
+28.63%
|
$79,535
$1.44 P/Share
|
|
Feb 22
2022
|
Kurt J Hilzinger |
BUY
Open market or private purchase
|
Direct |
95,597
+44.61%
|
$95,597
$1.49 P/Share
|
|
Feb 01
2022
|
Ghiath M. Sukhtian Director |
BUY
Other acquisition or disposition
|
Indirect |
2,500,000
+8.2%
|
$2,500,000
$1.25 P/Share
|
|
Feb 01
2022
|
Arun Kumar Pillai Director |
SELL
Other acquisition or disposition
|
Indirect |
2,500,000
-9.81%
|
$2,500,000
$1.25 P/Share
|
|
Dec 06
2021
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
25,201
+2.12%
|
$25,201
$1.38 P/Share
|
|
Dec 06
2021
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
25,000
+41.67%
|
$25,000
$1.39 P/Share
|
|
Dec 03
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
35,200
+2.9%
|
$35,200
$1.34 P/Share
|
|
Dec 03
2021
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.87%
|
$10,000
$1.42 P/Share
|
|
Dec 02
2021
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.4 P/Share
|
|
Dec 02
2021
|
Faisal Ghiath Sukhtian |
BUY
Open market or private purchase
|
Direct |
18,000
+32.14%
|
$18,000
$1.4 P/Share
|
|
Dec 02
2021
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$10,000
$1.39 P/Share
|
|
Nov 29
2021
|
Ghiath M. Sukhtian Director |
BUY
Open market or private purchase
|
Indirect |
16,000,000
+36.5%
|
$16,000,000
$1.25 P/Share
|
|
Apr 20
2021
|
Lawrence A Kenyon CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+34.57%
|
$10,000
$1.83 P/Share
|
|
Apr 19
2021
|
Faisal Ghiath Sukhtian |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$10,000
$1.82 P/Share
|
|
Apr 19
2021
|
Yezan Munther Haddadin |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$10,000
$1.82 P/Share
|
|
Feb 23
2021
|
Terry Dagnon Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
15,900
-1.39%
|
$31,800
$2.09 P/Share
|
|
Feb 23
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,554
-0.74%
|
$17,108
$2.09 P/Share
|
|
Feb 12
2021
|
Terry Dagnon Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
63,700
-5.28%
|
$127,400
$2.55 P/Share
|
|
Feb 12
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
56,973
-4.72%
|
$113,946
$2.55 P/Share
|
|
Feb 10
2021
|
Ghiath M. Sukhtian Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,013,627
+7.89%
|
$1,013,627
$1.0 P/Share
|
|
Feb 03
2021
|
Syntone Ventures LLC |
BUY
Open market or private purchase
|
Direct |
3,000,000
+13.14%
|
$3,000,000
$1.0 P/Share
|
|
Feb 02
2021
|
Ghiath M. Sukhtian Director |
BUY
Open market or private purchase
|
Indirect |
8,360,000
+43.59%
|
$8,360,000
$1.0 P/Share
|